Mereo BioPharma Group plc (NASDAQ:MREO) Receives $7.83 Consensus PT from Brokerages
Shares of Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) have been given an average rating of “Buy” by the seven research firms that are presently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a buy rating and three have given a strong buy rating to the company. […]
More Stories
Oracle Power (LON:ORCP) Stock Price Down 8.3% – What’s Next?
Oracle Power plc (LON:ORCP – Get Free Report)’s stock price traded down 8.3% during mid-day trading on Monday . The...
Congress Certifies Trump’s Election Victory
By Jackson Richman and Joseph Lord WASHINGTON—The U.S. Congress on Jan. 6 certified President-elect Donald Trump’s electoral victory in the...
Identillect Technologies (CVE:ID) Trading Down 50% – Time to Sell?
Identillect Technologies Corp. (CVE:ID – Get Free Report) was down 50% during trading on Monday . The company traded as...
Canadian Prime Minister Justin Trudeau Says He Is Resigning
By Omid Ghoreishi Canadian Prime Minister Justin Trudeau has announced he will resign as prime minister and Liberal leader after...
Head to Head Contrast: Innovex International (INVX) versus Its Rivals
Innovex International (NYSE:INVX – Get Free Report) is one of 25 publicly-traded companies in the “Oil & gas field machinery”...
Recruiter.com Group Appoints New CEO and Board Members
Recruiter.com Group, trading on the NASDAQ under the symbol RCRT, has recently made significant changes to its leadership team. In...